MyAverix Finance
F · Healthcare
OKYO PHARMA LTD SP.ADR/65 (OK10)
Biotechnology
OKYO PHARMA LTD SP.ADR/65 (OK10) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $38.38M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for OK10
OKYO PHARMA LTD SP.ADR/65 (OK10) — FAQ
What is OKYO PHARMA LTD SP.ADR/65's market cap?
OKYO PHARMA LTD SP.ADR/65 (OK10) has a reported market cap of $38.38M (data as of 2026-03-30).
What is OK10's P/E ratio?
The price-to-earnings (P/E) ratio for OKYO PHARMA LTD SP.ADR/65 (OK10) is 18.00 (data as of 2026-03-30).
Does OKYO PHARMA LTD SP.ADR/65 pay a dividend?
Dividend yield is not available in the current snapshot for OKYO PHARMA LTD SP.ADR/65 (OK10). Check the MyAverix Finance app for the latest dividend data.
What sector is OKYO PHARMA LTD SP.ADR/65 in?
OKYO PHARMA LTD SP.ADR/65 (OK10) is classified in the Healthcare sector (Biotechnology industry).
What exchange is OK10 listed on?
OK10 is listed on F.
What is OKYO PHARMA LTD SP.ADR/65's net margin?
OKYO PHARMA LTD SP.ADR/65 (OK10) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.